Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-09-03
1987-07-07
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546321, 546263, 546271, 546283, C07D21190, C07D40112, C07D40512, A61K 31455
Patent
active
046787968
ABSTRACT:
Novel 2-(2-alkoxy-2-oxoethylidene)-1,2,3,4-tetrahydro-6-methyl-4-[2-(substituted )phenyl]-3,5-pyridinedicarboxylic acid dialkyl ester derivatives having novel inotropic and hypotensive activity, processes for their manufacture, pharmaceutical compositions, and methods for using said compounds and compositions are described.
REFERENCES:
patent: 3905983 (1975-09-01), Bossert et al.
patent: 4532248 (1985-07-01), Franckowiak et al.
Loev, B. et al., J. Med. Chem. (1974), vol. 17, No. 9, pp. 956-965.
Meyer, H., Calcium Antagonists and Cardiovascular Disease, edited by L. H. Opie, Raven Press, New York (1984).
Schramm et al., "Novel Dihydropyridine, with Positive Inotropic Action", Nature, vol. 303, Jun. 9, 1983 (pp. 535-537).
Badger Edward W.
Taylor Michael D.
Bjorkman Dale A.
Jiles Henry R.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyrid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyrid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyrid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1663130